Regnery, Sebastian
Ristau, Jonas
Weykamp, Fabian
Hoegen, Philipp
Sprengel, Simon David
Paul, Katharina Maria
Buchele, Carolin
Klüter, Sebastian
Rippke, Carolin
Renkamp, Claudia Katharina
Pohl, Moritz
Meis, Jan
Welzel, Thomas
Adeberg, Sebastian
Koerber, Stefan Alexander
Debus, Jürgen
Hörner-Rieber, Juliane
Funding for this research was provided by:
National Center for Tumor diseases (NCT), Heidelberg (HD02-NCTC-MAGELLAN)
Medizinischen Fakultät Heidelberg, Universität Heidelberg (Physician Scientist-Programme)
Universitätsklinikum Heidelberg
Article History
Received: 31 January 2022
Accepted: 16 May 2022
First Online: 25 May 2022
Declarations
:
: This study will be conducted according to the declaration of Helsinki and was approved by the local ethics board (Ethikkommission der Medizinischen Fakultät Heidelberg; IRB number: S-208/2021). Written informed consent must be obtained from each patient before trial inclusion.
: Not applicable.
: J. H.-R. and S. K. received speaker fees and travel reimbursement from ViewRay Inc. S.A.K. and J.D. received grants from View-Ray Inc. J. H.-R. received travel reimbursement from IntraOP Medical and Elekta Instrument AB as well as grants from IntraOP Medical and Varian Medical Systems outside the submitted work. S.A. received grants from Accuray International Sàrl, Merck Serono GmbH and Novocure GmbH outside the submitted work. S.A. received consulting fees from Accuray International Sàrl and honoraria for lectures/presentations from Accuray International Sàrl and MSD outside the submitted work. S.A. received travel reimbursements from AstraZeneca outside the submitted work. S.A. participated on advisory boards for Sanofi Genzyme outside the submitted work. S.A.K. received honoraria from IBA dosimetry outside the submitted work. J.D. received grants from CRI—The Clinical Research Institute GmbH, Accuray Incorporated, Accuray International Sàrl, RaySearch Laboratories AB, Vision RT limited, Astellas Pharma GmbH, Astra Zeneca GmbH, Solution Akademie GmbH, Ergomed PLC Surrey Research Park, Merck Serono GmbH, Siemens Healthcare GmbH, Quintiles GmbH, Pharmaceutecal Research Associates GmbH, Boehringer Ingelheim Pharma GmbH Co, PTW-Freiburg Dr. Pychlau GmbH, Nanobiotix A.A., IntraOP Medical and Varian Medical Systems outside the submitted work.